“She is very knowledgeable and experienced, as well as very client-focused and easy to work with. She is critical to keeping the transaction going, giving very good advice.” - Chambers Global 2021
Dr. Mengyu Lu is a corporate partner in the Firm’s Hong Kong office. Dr. Lu has extensive experience advising on initial public offerings and listings on The Stock Exchange of Hong Kong Limited (“HKEx”), pre-IPO financings of issuers, mergers and acquisitions, and post-listing compliance matters.
IFLR named Dr. Lu to its list of 2021 “Asia Best Lawyers”. According to Chambers Asia-Pacific, a client praised her that “she managed the whole process and worked very hard. She's been very prompt, responsive and time-efficient, and has done a very good job.“ Asian Legal Business named her to its 2021 Asia “40 Under 40” list. Dr. Lu was also listed in China Business Law Journal “China’s Elite 100 Lawyers” in 2016–2018 and 2020–2021, and in Asian Legal Business “Top 15 Rising Lawyers” in 2017. Chambers Global and Chambers Asia-Pacific recognized Dr. Lu as a “Leading Lawyer” for China equity capital markets. IFLR1000 named her as a “Highly Regarded” lawyer for Hong Kong capital markets.
Dr. Lu is a native Mandarin speaker and is fluent in English and Cantonese.
“Leading Lawyer”, Capital Markets: Equity – China, Chambers Asia-Pacific (2022)
“Leading Lawyer”, Capital Markets: Equity – China, Chambers Global (2022)
“Highly Regarded”, Capital Markets: Equity, IFLR 1000 (2022)
“Highly Regarded”, Capital Markets: Debt, IFLR 1000 (2022)
“A-List China’s Elite 100 Lawyers”, China Business Law Journal (2021)
“Best Asia Lawyer”, IFLR Asia Best Lawyers (2021)
Asia “40 Under 40”, Asian Legal Business (2021)
“Up and Coming”, Capital Markets: Equity – China, Chambers Asia-Pacific (2021)
"Top 15 Rising Lawyers", Asian Legal Business (2017)
Admissions & Qualifications
- New York
- Hong Kong (Solicitor)
- Chinese Academy of Social SciencesPh.D., Economics
- Duke University School of LawLL.M.
- China University of Political Science and LawLL.B.